RxDoctor Payments Data

Shawn Sikka, MD

Pain Medicine · Leitchfield, KYNPI 1366797201

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,391 of the $3,044 with a category attached, or 78.5%. 15 manufacturers reported payments, led by Nevro Corp. at 43.2% of the total. That places this record below the midpoint for pain medicine clinicians in KY, where the typical reported total is $3,535.

$3,044in general payments, 2019–2025

Across 48 payments — averaging $63.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$1K
  • Stimwave Technologies Incorporated$654
  • Globus Medical$484
  • Saluda Medical Americas, Inc.$171
  • Medtronic$121
  • GRT US Holding, Inc.$104
  • plus $195 from 9 others

What the payments were for

  • Travel & lodging$65421%
  • Food & beverage$2,39179%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,044 in reported general payments places this provider in the 45th percentile of 90 pain medicine providers in Kentucky.

See all pain medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$89,237
Medicare patients
305
Services billed
943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen699$19,379
Nucynta ErTapentadol Hcl14$13,814
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen694$11,352
MovantikNaloxegol Oxalate16$9,392
Gabapentin671$8,557
Pregabalin108$7,628
SavellaMilnacipran Hcl12$5,747
Oxycodone Hcl221$3,170
Meloxicam66$2,322
Naloxone Hcl29$1,795
Morphine Sulfate ErMorphine Sulfate59$1,705
Tizanidine Hcl159$1,454
Hydromorphone Hcl89$904
Baclofen95$784
Tramadol Hcl100$649

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er$20$13,81414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 90 pain medicine providers in Kentucky.

Other pain medicine in Leitchfield

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →